{"nct_id":"NCT01111019","title":"Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2006-03-21","start_date_type":"ACTUAL","primary_completion_date":"2017-01-17","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-17","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}